Therapeutics

Developing Next Generation Therapeutics for Healthy Life

Pipeline
Immunology
Product(Partners)
Target
Indication
Region
Discovery
Preclinical
IND
PH1
PH2
PH3
BLA Filing
view more

Batoclimab HBM9161(HanAll)

FcRn

MG*

NMOSD*

TED*

ITP*

CIDP*

PV*

Greater
China

Greater
China

Greater
China

Greater
China

Greater
China

Greater
China

view more

Tanfanercept HBM9036(Hanall)

TNFα

Dry Eye Disease

Greater
China

HBM9378

TSLP

Asthma

Global

HBM9022(AbbVie; Utrecht University; Erasmus MC)

SARS-COV-2

COVID-19

Global License to AbbVie

Oncology/Immnuo-Oncology
Product(Partners)
Target
Indication
Region
Discovery
Preclinical
IND
PH1
PH2
PH3
BLA Filing
view more

HBM4003

CTLA-4

Advanced Solid Tumors

Advanced Melanoma & Other Solid Tumors

Advanced NSCLC & Other Solid Tumors

Global

Global

Global

HBM7022

Claudin18.2xCD3

Solid Tumors

Global License to AstraZeneca

HBM1007

CD73

Solid Tumors

Global

HBM7020

BCMAxCD3

Multiple Myeloma

Ex-Greater China

HBM7008

B7H4x4-1BB

Solid Tumors

Global

HBM1022

CCR8

Solid Tumors

Global

view more

HBM1020

B7H7

Solid Tumors

Global

  • HBM

  • Partner

  • Registrational Clinical Trial

  • Monotherapy

  • PD1 / Chemo

Greater China rights out-licensed to Hualan Genetics

* MG = Myasthenia Gravis

* NMOSD = Neuromyelitis Optica Spectrum Disorder

* ITP = Immune Thrombocytopenic Purpura

* TED = Thyroid Eye Disease

* CIDP = Chronic Inflammatory Demyelinating Polyradiculoneuropathy

* PV = Pemphigus Vulgaris

* HCC = Hepatocellular Carcinoma

* NEN = Neuroendocrine Neoplasms

* NSCLC = Non-Small Cell Lung Cancer

Publications